Interventional, randomized, double-blind, active-controlled, fixed-dose study of Lu AF35700 in patients with Treatment resistant Schizophrenia
Investigational product being tested for treatment resistant schizophrenia
Sponsor: H. Lundbeck AS
Enrolling: Male and Female Patients
IRB Number: 7317
U.S. Govt. ID: NCT02717195
Contact: James Gangwisch PhD: 646-774-8433 / jeg64@columbia.edu
Additional Study Information: Lu AF35700 is an investigational product that is being tested for treatment resistant schizophrenia. Non-acute male and female patients, aged 18-60 years, with a primary diagnosis of schizophrenia according to the DSM-5 who meet criteria of treatment resistance will be screened for eligibility.
This study is closed
Investigator
Joshua Kantrowitz, MD
Do You Qualify?
Do you suffer from schizophrenia? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
James Gangwisch PhD
jeg64@columbia.edu
646-774-8433
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE